GGrantIndex
← Leaderboards

F. Michael Hoffmann

University Of Wisconsin Madison

$8,332,757
Attributed
$8,332,757
Total exposure
10
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $874K · FY200523
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$8,332,757 · 10

By mechanism

U19$3,363,252 · 3
T32$1,938,578 · 1
R01$1,288,864 · 1
P30$1,193,532 · 2
R21$548,531 · 2
P50$0 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Wisconsin Madison

Same institution · by research overlap

Others in their field

Top investigators on “Small Molecule

Research focus

Small MoleculeServicesBaseIn VivoIn VitroLiquid SubstanceRoboticsPharmaceutical PreparationsLaboratoriesHigh Throughput ScreeningFundingDrug DevelopmentProgramsScientistPhenotypeComprehensive Cancer CenterScreeningSamplingResearch PersonnelSecureCellsDoseReaderEnsure

Grant awards (35)

In vitro core$621,584
U19 · FY2023 · AI · contact PI
In vitro core$531,472
U19 · FY2022 · AI · contact PI
In vitro core$567,713
U19 · FY2021 · AI · contact PI
In vitro core$723,182
U19 · FY2020 · AI · contact PI
In vitro core$654,825
U19 · FY2019 · AI · contact PI
Drug Development Core Shared Resource$219,185
P30 · FY2019 · CA · contact PI
Drug Development Core Shared Resource$220,222
P30 · FY2018 · CA · contact PI
Drug Development Core Shared Resource$10,869
P30 · FY2018 · CA · contact PI
Drug Development Core Shared Resource$5,923
P30 · FY2018 · CA · contact PI
Drug Development Core Shared Resource$3,291
P30 · FY2018 · CA · contact PI
Drug Development Core Shared Resource$1,525
P30 · FY2018 · CA · contact PI
The Role of Viruses in Human Cancer$365,742
P30 · FY2010 · GM · contact PI
The Role of Viruses in Human Cancer$366,775
P30 · FY2009 · GM · contact PI
Targeting Smad3-Ski for Therapeutic Development in Pancreatic Cancer$200,475
R21 · FY2009 · CA · contact PI
In Vitro Screening of New Compounds and Analogs in Cell-Based Assays$61,040
U19 · FY2009 · CA · contact PI
Targeting Smad3-Ski for Therapeutic Development in Pancreatic Cancer$167,063
R21 · FY2008 · CA · contact PI
In Vitro Screening of New Compounds and Analogs in Cell-Based Assays$60,672
U19 · FY2008 · CA · contact PI
Molecular Mechs.Regulating Cancer Cell Proliferation$290,142
T32 · FY2007 · CA · contact PI
In Vitro Screening of New Compounds and Analogs in Cell-Based Assays$61,475
U19 · FY2007 · CA · contact PI
Molecular Mechs.Regulating Cancer Cell Proliferation$314,174
T32 · FY2006 · CA · contact PI
Chemical Genetics of TGF-Beta Signal Transduction$252,904
R01 · FY2006 · CA · contact PI
An HTS Assay for Inhibitors of Smad-dependent Transcriptional Responses to TGF-be$180,993
R21 · FY2006 · NS · contact PI
In Vitro Screening of New Compounds and Analogs in Cell-Based Assays$40,732
U19 · FY2006 · CA · contact PI
Chemical Genetics of TGF-Beta Signal Transduction$258,990
R01 · FY2005 · CA
Molecular Mechs.Regulating Cancer Cell Proliferation$161,160
T32 · FY2005 · CA
In Vitro Screening of New Compounds and Analogs in Cell-Based Assays$40,557
U19 · FY2005 · CA
Molecular Mechs.Regulating Cancer Cell Proliferation$300,757
T32 · FY2004 · CA
Chemical Genetics of TGF-Beta Signal Transduction$258,990
R01 · FY2004 · CA
Molecular Mechs.Regulating Cancer Cell Proliferation$260,202
T32 · FY2003 · CA
Chemical Genetics of TGF-Beta Signal Transduction$258,990
R01 · FY2003 · CA
Pilot -- Using Peptide Aptamers to Inhibit Smad3$0
P50 · FY2003 · DK
MOLECULAR MECHS REGULATING CANCER CELL PROLIFERATION$264,517
T32 · FY2002 · CA
Chemical Genetics of TGF-Beta Signal Transduction$258,990
R01 · FY2002 · CA
MOLECULAR MECHS REGULATING CANCER CELL PROLIFERATION$134,162
T32 · FY2001 · CA
MOLECULAR MECHS REGULATING CANCER CELL PROLIFERATION$213,464
T32 · FY2000 · CA